Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Russian vaccine tourism catches on after Sputnik V hits WHO snag

Published 22/09/2021, 17:04
© Reuters. FILE PHOTO: A medical worker fills a syringe with Pfizer-BioNTech vaccine at the COVID-19 vaccination centre of 'Healthcare Centre' in Nis, Serbia, March 3, 2021. REUTERS/Marko Djurica/File Photo
PFE
-

MOSCOW (Reuters) - Russian travel agencies are selling package tours for Russians to receive foreign COVID-19 vaccines abroad amid frustration among some Russians that their domestically produced vaccines have not been approved internationally.

Russia has not registered any foreign-made vaccines for use. It has approved four domestically produced vaccines including the two-dose Sputnik V. None of Russia's shots are approved by the World Health Organisation or European Union.

The WHO has suspended its approval process for Sputnik V until a factory that failed a good practices inspection is visited again, the Pan American Health Organization said on Sept. 15.

Demand in Russia for tours allowing people to receive foreign vaccines approved by the WHO has risen since that announcement last week, said Maya Lomidze, director of Russia's Association of Tour Operators (ATOR).

Most of the trips, costing around 600-850 euros, are to Serbia, and one firm was offering Germany as a destination. They allow customers to receive one of four different vaccines, including the one developed with Pfizer (NYSE:PFE), ATOR said in a statement.

If the travellers choose a two-dose vaccine, they need to book two trips.

Anna Filatovskaya, the PR director of Russian Express, a travel agency offering such tours, said that clients were choosing the Pfizer shot most often.

She said its package tours included return flights with Aeroflot, two-three nights in a hotel in Belgrade, breakfast and travel to a clinic. The vaccine shot itself is free, but the travel agency registers clients to receive it, she said.

"We started selling these tours around two weeks ago. There were around 20 applications in that time ... " she said.

Demand spiked on Wednesday after local media reports of the availability of such tours, she said.

"This provoked wild demand," she told Reuters. She said 17 people had applied for a vaccination trip on Wednesday.

Ivetta Verdiyan, the advertising director of another travel agency, said their tours were mainly being used by Russians who travel for business or whose children study abroad.

© Reuters. FILE PHOTO: A medical worker fills a syringe with Pfizer-BioNTech vaccine at the COVID-19 vaccination centre of 'Healthcare Centre' in Nis, Serbia, March 3, 2021. REUTERS/Marko Djurica/File Photo

Maria, a Moscow resident, said she travelled abroad this summer to get vaccinated, though she did not use one of these tours.

"I trust Sputnik – but it is not recognised outside of Russia. Travel rules in the world mean I need an international certificate to move around for work," she said, declining to give her family name.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.